Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Advanced colorectal cancer is a significant cause of cancer mortality in industrialized countries. 5-fluorouracil has remained the principal drug used in treating this disease, and although it has tangibly improved patient outcome, further gains can potentially be made. This review focuses on the current development of novel therapeutic agents which have potential in the treatment of colorectal cancer.

Type

Journal article

Journal

Hosp Med

Publication Date

08/1998

Volume

59

Pages

617 - 621

Keywords

Colorectal Neoplasms, Enzyme Inhibitors, Genetic Therapy, Humans, Immunotherapy, Thymidylate Synthase, Topoisomerase I Inhibitors